Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free EPC Stock Alerts

Edgewell Personal Care (EPC) Financials

Edgewell Personal Care logo
$17.80 +0.28 (+1.62%)
Closing price 03:59 PM Eastern
Extended Trading
$17.80 -0.01 (-0.05%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Edgewell Personal Care

Annual Income Statements for Edgewell Personal Care

This table shows Edgewell Personal Care's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 -275 179 5.70 103 570 68 118 100 115 99 25
Consolidated Net Income / (Loss)		 -275 179 5.70 103 -372 68 118 100 115 99 25
Net Income / (Loss) Continuing Operations		 -296 179 5.70 103 570 68 118 100 115 99 25
Total Pre-Tax Income 		-459 220 -53 164 -390 87 147 124 148 121 24
Total Operating Income		 -199 295 -1.10 215 244 176 240 182 227 199 97
Total Gross Profit		 1,184 1,160 1,126 1,033 967 881 951 881 941 956 925
Total Revenue		 2,421 2,362 2,298 2,234 2,141 1,950 2,087 2,172 2,252 2,254 2,224
Operating Revenue		 2,421 2,362 2,298 2,234 2,141 1,950 2,087 2,172 2,252 2,254 2,224
Total Cost of Revenue		 1,237 1,202 1,173 1,202 1,174 1,069 1,136 1,291 1,311 1,298 1,299
Operating Cost of Revenue		 1,237 1,202 1,173 1,202 1,174 1,069 1,136 1,291 1,311 1,298 1,299
Total Operating Expenses		 1,383 865 1,127 818 351 705 711 698 714 756 828
Selling, General & Admin Expense		 572 413 393 395 - 409 391 389 410 430 425
Marketing Expense		 367 337 318 293 251 216 242 238 229 232 247
Research & Development Expense		 71 72 68 61 54 55 58 56 59 58 58
Impairment Charge		 318 6.50 319 24 - - - - 0.00 0.00 51
Restructuring Charge		 55 37 30 39 46 25 21 15 17 36 48
Total Other Income / (Expense), net		 -260 -75 -52 -51 -64 -89 -93 -58 -79 -78 -73
Interest Expense		 100 72 69 68 63 87 94 71 79 77 73
Other Income / (Expense), net		 -81 -3.40 17 17 -1.50 -1.30 1.20 13 -0.80 -1.90 0.20
Income Tax Expense		 -163 41 -59 61 -18 20 29 25 33 22 -1.80
Basic Earnings per Share		 ($4.44) $3.02 $0.10 $1.90 ($6.88) $1.25 $2.17 $1.87 $2.24 $1.98 $0.53
Weighted Average Basic Shares Outstanding		 62M 59.20M 57.30M 54.40M 54.21M 54.36M 54.37M 51.44M 51.20M 49.70M 47.50M
Diluted Earnings per Share		 ($4.44) $2.99 $0.10 $1.90 ($6.88) $1.24 $2.13 $1.85 $2.21 $1.97 $0.53
Weighted Average Diluted Shares Outstanding		 62M 59.20M 57.30M 54.40M 54.21M 54.36M 54.37M 51.44M 51.80M 50.10M 47.60M
Weighted Average Basic & Diluted Shares Outstanding		 62M 59.20M 57.30M 54.40M 54.21M 54.36M 54.37M 51.44M 50.02M 48.72M 46.46M
Cash Dividends to Common per Share		 $1.50 - - - - - - - - $0.60 $0.60

Quarterly Income Statements for Edgewell Personal Care

This table shows Edgewell Personal Care's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 30 4.80 36 49 8.80 -2.10 29 29 -31 -66 -11
Consolidated Net Income / (Loss)		 30 4.80 36 49 8.80 -2.10 29 29 -31 -66 -11
Net Income / (Loss) Continuing Operations		 30 4.80 36 49 8.80 -10 21 29 -31 -29 4.00
Total Pre-Tax Income 		33 6.00 47 63 5.40 -13 31 37 -53 -37 7.90
Total Operating Income		 52 26 70 83 20 9.30 49 54 -36 -19 18
Total Gross Profit		 229 198 258 287 213 173 237 269 209 161 217
Total Revenue		 534 489 599 648 518 415 517 627 537 423 520
Operating Revenue		 534 489 599 648 518 415 517 627 537 423 520
Total Cost of Revenue		 306 291 341 361 305 243 280 359 329 262 303
Operating Cost of Revenue		 306 291 341 361 305 243 280 359 329 262 303
Total Operating Expenses		 177 172 188 204 192 163 188 215 245 180 199
Selling, General & Admin Expense		 112 103 108 110 109 100 103 104 112 102 111
Marketing Expense		 40 48 63 77 44 46 60 80 51 46 59
Research & Development Expense		 16 13 14 15 16 13 13 14 16 14 15
Restructuring Charge		 7.90 6.80 3.20 3.10 23 4.10 12 16 16 18 14
Total Other Income / (Expense), net		 -19 -20 -23 -20 -15 -22 -18 -17 -17 -18 -11
Interest Expense		 19 20 20 19 18 19 20 19 15 19 18
Other Income / (Expense), net		 -0.10 -0.30 -2.70 -1.40 2.50 -3.20 2.60 2.90 -2.10 1.30 7.40
Income Tax Expense		 3.40 1.20 11 14 -3.40 -2.60 11 8.10 -23 -7.70 3.90
Net Income / (Loss) Discontinued Operations		 - - - - - 8.00 8.20 - - -37 -15
Basic Earnings per Share		 $0.58 $0.10 $0.72 $0.99 $0.17 ($0.04) $0.60 $0.62 ($0.65) ($1.41) ($0.23)
Weighted Average Basic Shares Outstanding		 50.02M 50.10M 49.80M 49.50M 48.72M 48.70M 48M 46.80M 47.50M 46.60M 46.50M
Diluted Earnings per Share		 $0.58 $0.09 $0.72 $0.98 $0.18 ($0.04) $0.60 $0.62 ($0.65) ($1.41) ($0.22)
Weighted Average Diluted Shares Outstanding		 50.02M 50.50M 50.20M 50.10M 48.72M 48.70M 48.20M 47M 47.60M 46.60M 46.80M
Weighted Average Basic & Diluted Shares Outstanding		 50.02M 49.93M 49.55M 49.31M 48.72M 48.23M 47.03M 46.46M 46.46M 46.72M 46.08M
Cash Dividends to Common per Share		 - - $0.15 - - $0.15 $0.15 - - $0.15 $0.15

Annual Cash Flow Statements for Edgewell Personal Care

This table details how cash moves in and out of Edgewell Personal Care's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Change in Cash & Equivalents		 -417 27 -236 -237 75 23 115 -291 27 2.40 17
Net Cash From Operating Activities		 149 187 314 259 191 233 229 102 -216 -231 118
Net Cash From Continuing Operating Activities		 149 187 314 259 191 233 229 102 216 231 118
Net Income / (Loss) Continuing Operations		 -275 179 5.70 103 -372 68 118 100 115 99 25
Consolidated Net Income / (Loss)		 -275 179 5.70 103 -372 68 118 100 115 99 25
Depreciation Expense		 115 93 94 98 94 89 87 90 91 88 89
Non-Cash Adjustments To Reconcile Net Income		 521 27 324 41 582 44 54 25 38 27 78
Changes in Operating Assets and Liabilities, net		 -212 -111 -110 18 -113 33 -30 -113 -28 17 -73
Net Cash From Investing Activities		 -175 -70 -85 -119 -46 -196 -49 -355 -51 -62 -73
Net Cash From Continuing Investing Activities		 -175 -70 -85 -119 -46 -196 -49 -355 -43 -49 -73
Purchase of Property, Plant & Equipment		 -99 -70 -69 -62 -58 -48 -57 -56 -50 -57 -77
Other Investing Activities, net		 14 - 0.00 9.70 8.40 2.90 0.90 5.40 6.40 7.30 4.10
Net Cash From Financing Activities		 -327 -93 -478 -380 -64 -19 -65 -18 -147 -179 -30
Net Cash From Continuing Financing Activities		 -327 -93 -478 -380 -64 -19 -65 -18 -147 -179 -30
Repayment of Debt		 -2,168 -653 -586 -798 -509 -67 -526 -556 -872 -896 -840
Repurchase of Common Equity		 -175 -197 -165 -124 0.00 0.00 -9.20 -125 -75 -59 -90
Payment of Dividends		 -93 - - - 0.00 0.00 -26 -33 -32 -31 -29
Issuance of Debt		 2,604 756 273 550 440 50 500 707 841 813 937
Other Financing Activities, net		 -500 - - -7.50 5.40 -2.00 -4.20 -11 -9.00 -7.30 -7.50
Effect of Exchange Rate Changes		 -64 2.90 13 2.50 -6.10 5.60 -0.40 -20 - - 1.10
Cash Interest Paid		 164 71 66 67 61 56 61 68 74 63 73
Cash Income Taxes Paid		 55 28 14 22 58 25 25 24 46 34 26

Quarterly Cash Flow Statements for Edgewell Personal Care

This table details how cash moves in and out of Edgewell Personal Care's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 27 -10 -18 -0.10 13 -34 -5.40 30 26 -2.40 76
Net Cash From Operating Activities		 48 -73 129 101 74 -116 45 115 74 -126 54
Net Cash From Continuing Operating Activities		 55 -73 129 101 74 -116 45 115 74 -126 54
Net Income / (Loss) Continuing Operations		 30 4.80 36 49 8.80 -2.10 29 29 -31 -66 -11
Consolidated Net Income / (Loss)		 30 4.80 36 49 8.80 -2.10 29 29 -31 -66 -11
Depreciation Expense		 23 23 22 22 21 22 22 22 23 21 19
Non-Cash Adjustments To Reconcile Net Income		 17 7.10 6.40 7.20 6.50 7.50 6.40 6.60 57 45 5.10
Changes in Operating Assets and Liabilities, net		 -15 -107 64 23 37 -143 -12 57 25 -126 41
Net Cash From Investing Activities		 -19 -6.00 -14 -17 -26 -16 -17 -12 -28 -9.90 325
Net Cash From Continuing Investing Activities		 -23 -7.00 -14 -17 -26 -16 -17 -12 -28 -9.90 325
Purchase of Property, Plant & Equipment		 -18 -6.50 -12 -13 -26 -17 -17 -16 -28 -12 -14
Other Investing Activities, net		 -4.50 -0.50 -2.20 -4.60 0.40 1.10 -0.20 3.20 - 1.70 0.10
Net Cash From Financing Activities		 -14 70 -129 -80 -40 110 -37 -83 -19 133 -301
Net Cash From Continuing Financing Activities		 -14 70 -129 -80 -40 110 -37 -83 -19 133 -301
Repayment of Debt		 -158 -126 -106 -693 -197 152 5.60 -47 -949 -151 -386
Repurchase of Common Equity		 -30 -15 -15 -9.90 -18 -30 -35 -25 - 0.00 -16
Payment of Dividends		 -7.70 -7.60 -8.20 -7.50 -7.40 -7.90 -7.30 -7.20 -6.90 -7.40 -7.10
Issuance of Debt		 191 220 -0.20 631 182 3.70 -0.20 -4.30 937 294 108
Effect of Exchange Rate Changes		 - - -4.10 -4.20 4.90 -12 4.20 10 -1.30 0.00 -2.10

Annual Balance Sheets for Edgewell Personal Care

This table presents Edgewell Personal Care's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Total Assets		 4,986 4,772 4,189 3,953 3,421 3,541 3,675 3,713 3,741 3,731 3,756
Total Current Assets		 1,637 1,452 1,186 951 1,044 984 1,136 942 962 936 996
Cash & Equivalents		 712 739 503 266 342 365 479 189 216 209 226
Accounts Receivable		 280 261 224 227 206 159 151 137 106 109 138
Inventories, net		 333 309 334 330 357 314 346 449 492 477 434
Prepaid Expenses		 312 143 126 129 140 146 160 167 147 140 139
Other Current Nonoperating Assets		 - - - - - - - - - - 60
Plant, Property, & Equipment, net		 499 486 453 424 396 371 363 346 338 349 295
Total Noncurrent Assets		 2,851 2,833 2,549 2,578 1,981 2,186 2,176 2,425 2,440 2,446 2,466
Goodwill		 1,422 1,420 1,446 1,451 1,033 1,160 1,163 1,322 1,331 1,339 1,137
Intangible Assets		 1,409 1,385 1,072 1,099 913 928 906 997 974 949 828
Other Noncurrent Operating Assets		 21 28 32 28 35 99 107 107 135 159 179
Other Noncurrent Nonoperating Assets		 - - - - - - - - - - 322
Total Liabilities & Shareholders' Equity		 4,986 4,772 4,189 3,953 3,421 3,541 3,675 3,713 3,741 3,731 3,756
Total Liabilities		 3,122 2,943 2,447 2,209 2,117 2,108 2,090 2,246 2,200 2,147 2,203
Total Current Liabilities		 667 868 524 717 660 511 537 540 523 564 566
Short-Term Debt		 18 300 19 193 131 21 27 19 20 25 30
Accounts Payable		 237 197 224 238 223 182 210 229 194 219 220
Other Current Liabilities		 412 371 281 286 305 308 301 292 310 320 311
Other Current Nonoperating Liabilities		 - - - - - - - - - - 5.20
Total Noncurrent Liabilities		 2,455 2,074 1,923 1,492 1,458 1,598 1,554 1,707 1,677 1,583 1,638
Long-Term Debt		 1,699 1,544 1,525 1,104 1,098 1,238 1,234 1,391 1,361 1,275 1,383
Noncurrent Deferred & Payable Income Tax Liabilities		 336 255 182 176 101 103 129 140 136 133 119
Other Noncurrent Operating Liabilities		 421 275 216 212 259 257 190 175 180 175 136
Total Equity & Noncontrolling Interests		 1,864 1,829 1,742 1,745 1,304 1,433 1,584 1,467 1,541 1,584 1,553
Total Preferred & Common Equity		 1,864 1,829 1,742 1,745 1,304 1,433 1,584 1,467 1,541 1,584 1,553
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,864 1,829 1,742 1,745 1,304 1,433 1,584 1,467 1,541 1,584 1,553
Common Stock		 1,645 1,643 1,624 1,629 1,628 1,633 1,632 1,605 1,595 1,587 1,580
Retained Earnings		 773 946 953 1,083 715 782 866 939 1,022 1,090 1,087
Treasury Stock		 -382 -563 -704 -819 -804 -790 -776 -861 -906 -938 -1,003
Accumulated Other Comprehensive Income / (Loss)		 -172 -197 -131 -148 -236 -192 -137 -216 -170 -155 -110

Quarterly Balance Sheets for Edgewell Personal Care

This table presents Edgewell Personal Care's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 6/30/2022 3/31/2023 6/30/2023 12/31/2023 3/31/2024 6/30/2024 12/31/2024 3/31/2025 6/30/2025 12/31/2025 3/31/2026
Total Assets		 3,721 3,799 3,766 3,787 3,756 3,708 3,702 3,773 3,793 3,768 3,533
Total Current Assets		 934 1,009 989 1,006 995 959 945 1,012 1,005 1,057 1,110
Cash & Equivalents		 182 155 207 214 196 196 176 170 200 223 300
Accounts Receivable		 155 161 122 113 131 155 121 178 153 154 185
Inventories, net		 414 541 503 522 496 456 502 512 488 461 450
Prepaid Expenses		 183 153 157 157 172 152 148 152 164 162 174
Other Current Nonoperating Assets		 - - - - - - - - - 57 0.00
Plant, Property, & Equipment, net		 348 342 340 334 328 325 343 345 356 293 290
Total Noncurrent Assets		 2,440 2,447 2,438 2,448 2,434 2,424 2,415 2,416 2,433 2,418 2,134
Goodwill		 1,332 1,334 1,336 1,337 1,334 1,333 1,329 1,333 1,343 1,137 1,135
Intangible Assets		 1,011 990 984 970 960 952 934 930 929 822 813
Other Noncurrent Operating Assets		 97 123 118 141 140 139 152 153 161 179 186
Other Noncurrent Nonoperating Assets		 - - - - - - - - - 280 0.00
Total Liabilities & Shareholders' Equity		 3,721 3,799 3,766 3,787 3,756 3,708 3,702 3,773 3,793 3,768 3,533
Total Liabilities		 2,243 2,292 2,215 2,241 2,205 2,132 2,201 2,259 2,225 2,282 2,085
Total Current Liabilities		 575 569 580 468 542 535 459 536 567 498 614
Short-Term Debt		 19 22 18 24 24 21 27 27 23 33 35
Accounts Payable		 239 245 241 198 220 209 204 216 225 213 231
Other Current Liabilities		 317 302 321 246 299 305 228 294 320 248 348
Other Current Nonoperating Liabilities		 - - - - - - - - - 4.00 0.00
Total Noncurrent Liabilities		 1,668 1,723 1,635 1,774 1,663 1,597 1,742 1,723 1,658 1,784 1,471
Long-Term Debt		 1,357 1,414 1,323 1,452 1,351 1,290 1,441 1,433 1,373 1,521 1,244
Noncurrent Deferred & Payable Income Tax Liabilities		 138 142 142 137 136 137 133 133 134 118 80
Other Noncurrent Operating Liabilities		 173 167 170 185 176 169 169 157 152 145 147
Total Equity & Noncontrolling Interests		 1,478 1,507 1,551 1,546 1,551 1,577 1,501 1,514 1,568 1,486 1,448
Total Preferred & Common Equity		 1,478 1,507 1,551 1,546 1,551 1,577 1,501 1,514 1,568 1,486 1,448
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,478 1,507 1,551 1,546 1,551 1,577 1,501 1,514 1,568 1,486 1,448
Common Stock		 1,601 1,584 1,587 1,570 1,575 1,582 1,563 1,568 1,574 1,561 1,565
Retained Earnings		 906 946 991 1,019 1,048 1,089 1,081 1,102 1,124 1,014 996
Treasury Stock		 -847 -864 -876 -897 -911 -921 -945 -979 -1,004 -985 -998
Accumulated Other Comprehensive Income / (Loss)		 -182 -160 -151 -147 -160 -173 -198 -177 -127 -105 -115

Annual Metrics And Ratios for Edgewell Personal Care

This table displays calculated financial ratios and metrics derived from Edgewell Personal Care's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -7.31% -2.45% -2.69% -2.78% -4.18% -8.94% 7.06% 4.04% 3.68% 0.09% -1.34%
EBITDA Growth		 -140.97% 333.90% -71.19% 197.56% 2.03% -21.60% 24.55% -13.04% 11.28% -10.14% -34.97%
EBIT Growth		 -205.59% 204.33% -94.41% 1,322.09% 4.53% -27.90% 38.01% -18.91% 15.70% -12.73% -50.96%
NOPAT Growth		 -165.00% 272.07% -100.32% 17,717.17% 25.81% -20.14% 40.97% -23.92% 20.61% -7.80% -36.04%
Net Income Growth		 -177.31% 164.91% -96.81% 1,712.28% -460.31% 118.16% 74.26% -15.53% 15.28% -14.04% -74.24%
EPS Growth		 -178.03% 167.34% -96.66% 1,800.00% -462.11% 118.02% 71.77% -13.15% 19.46% -10.86% -73.10%
Operating Cash Flow Growth		 -73.99% 25.54% 67.88% -17.28% -26.52% 22.04% -1.55% -55.46% 111.86% 6.90% 151.26%
Free Cash Flow Firm Growth		 -49.59% -74.30% -13.32% -4.05% 423.52% -99.98% 83,297.14% -215.19% 190.92% 19.63% -80.10%
Invested Capital Growth		 -22.10% 2.32% -5.15% -0.31% -21.04% 6.21% 1.66% 13.65% 0.58% -1.10% 2.46%
Revenue Q/Q Growth		 107.47% 2.18% -1.95% -1.22% -0.44% -1.97% 2.68% -0.29% -0.12% -0.73% 0.89%
EBITDA Q/Q Growth		 -658.84% 11,745.45% -74.12% 505.51% 233.90% -68.96% 7.01% -0.38% -3.08% -9.80% -24.28%
EBIT Q/Q Growth		 -172.78% 409.33% -95.12% 637.82% 170.35% -76.97% 10.85% -1.36% -4.48% -12.85% -38.77%
NOPAT Q/Q Growth		 -94.24% 500.22% -100.30% 400.45% 170.52% -78.61% 15.83% -9.15% 0.34% -12.53% -13.97%
Net Income Q/Q Growth		 -1,036.39% 292.15% -97.24% 260.16% 5.41% -22.57% 25.45% -9.38% -3.94% -17.63% -60.80%
EPS Q/Q Growth		 -1,044.68% 289.24% -97.24% 259.66% 5.36% -22.98% 25.29% -7.96% -3.07% -16.88% -61.03%
Operating Cash Flow Q/Q Growth		 -31.43% 44.58% -1.29% -27.96% 8.23% 10.24% -15.15% -29.90% 9.20% 12.63% 0.34%
Free Cash Flow Firm Q/Q Growth		 -41.89% -71.81% -41.01% -31.34% 202.94% -99.98% 381.44% 1.16% -1.65% 8.04% -21.66%
Invested Capital Q/Q Growth		 -23.13% -3.99% -8.94% -0.95% -5.17% 10.18% 1.43% 0.62% 0.74% -0.66% -0.87%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 48.89% 49.11% 48.99% 46.23% 45.15% 45.18% 45.57% 40.54% 41.78% 42.41% 41.60%
EBITDA Margin		 -6.79% 16.27% 4.82% 14.74% 15.70% 13.51% 15.72% 13.14% 14.11% 12.66% 8.35%
Operating Margin		 -8.22% 12.49% -0.05% 9.63% 11.39% 9.03% 11.49% 8.39% 10.08% 8.84% 4.34%
EBIT Margin		 -11.55% 12.35% 0.71% 10.37% 11.32% 8.96% 11.55% 9.00% 10.05% 8.76% 4.35%
Profit (Net Income) Margin		 -11.37% 7.57% 0.25% 4.62% -17.38% 3.47% 5.64% 4.58% 5.09% 4.38% 1.14%
Tax Burden Percent		 60.02% 81.26% -10.78% 63.06% 95.36% 77.43% 80.08% 80.18% 77.66% 81.56% 107.63%
Interest Burden Percent		 164.06% 75.39% -324.54% 70.66% -161.08% 49.97% 61.01% 63.48% 65.30% 61.25% 24.38%
Effective Tax Rate		 0.00% 18.74% 0.00% 36.94% 0.00% 22.57% 19.92% 19.82% 22.34% 18.45% -7.63%
Return on Invested Capital (ROIC)		 -4.26% 8.27% -0.03% 4.88% 6.87% 6.03% 8.19% 5.78% 6.54% 6.04% 3.84%
ROIC Less NNEP Spread (ROIC-NNEP)		 -16.82% 2.47% 0.58% 1.76% -49.73% -1.68% -0.68% 1.12% 1.37% 0.37% -3.06%
Return on Net Nonoperating Assets (RNNOA)		 -8.30% 1.41% 0.35% 1.05% -31.29% -1.09% -0.38% 0.74% 1.09% 0.27% -2.22%
Return on Equity (ROE)		 -12.55% 9.68% 0.32% 5.93% -24.42% 4.94% 7.81% 6.52% 7.63% 6.31% 1.62%
Cash Return on Invested Capital (CROIC)		 20.59% 5.97% 5.25% 5.19% 30.39% 0.01% 6.54% -7.00% 5.96% 7.15% 1.41%
Operating Return on Assets (OROA)		 -4.69% 5.98% 0.36% 5.69% 6.57% 5.02% 6.68% 5.29% 6.07% 5.28% 2.59%
Return on Assets (ROA)		 -4.62% 3.66% 0.13% 2.54% -10.09% 1.94% 3.27% 2.69% 3.08% 2.64% 0.68%
Return on Common Equity (ROCE)		 -12.55% 9.68% 0.32% 5.93% -24.42% 4.94% 7.81% 6.52% 7.63% 6.31% 1.62%
Return on Equity Simple (ROE_SIMPLE)		 -14.77% 9.77% 0.33% 5.92% -28.55% 4.72% 7.44% 6.78% 7.45% 6.22% 0.00%
Net Operating Profit after Tax (NOPAT)		 -139 240 -0.77 136 171 136 192 146 176 163 104
NOPAT Margin		 -5.76% 10.15% -0.03% 6.07% 7.97% 6.99% 9.20% 6.73% 7.83% 7.21% 4.68%
Net Nonoperating Expense Percent (NNEP)		 12.57% 5.79% -0.60% 3.12% 56.60% 7.71% 8.87% 4.66% 5.16% 5.67% 6.90%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - - 3.51%
Cost of Revenue to Revenue		 51.11% 50.89% 51.01% 53.77% 54.85% 54.82% 54.43% 59.46% 58.22% 57.59% 58.40%
SG&A Expenses to Revenue		 23.61% 17.47% 17.08% 17.68% 0.00% 20.97% 18.74% 17.92% 18.19% 19.08% 19.11%
R&D to Revenue		 2.93% 3.04% 2.94% 2.73% 2.50% 2.84% 2.77% 2.56% 2.60% 2.59% 2.59%
Operating Expenses to Revenue		 57.12% 36.61% 49.03% 36.60% 16.38% 36.15% 34.08% 32.15% 31.70% 33.56% 37.25%
Earnings before Interest and Taxes (EBIT)		 -280 292 16 232 242 175 241 196 226 197 97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -164 384 111 329 336 264 328 285 318 285 186
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.57 2.42 2.24 1.35 1.27 1.00 1.19 1.28 1.20 1.13 0.61
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.98 1.87 1.70 1.05 0.77 0.73 0.91 0.87 0.82 0.80 0.43
Price to Earnings (P/E)		 0.00 24.73 685.73 22.80 2.91 21.14 16.05 18.89 16.12 18.17 37.24
Dividend Yield		 48.29% 0.00% 0.00% 0.00% 0.00% 0.00% 1.72% 1.65% 1.65% 1.65% 2.95%
Earnings Yield		 0.00% 4.04% 0.15% 4.39% 34.35% 4.73% 6.23% 5.29% 6.21% 5.50% 2.69%
Enterprise Value to Invested Capital (EV/IC)		 2.02 1.88 1.78 1.22 1.16 1.00 1.13 1.15 1.11 1.08 0.78
Enterprise Value to Revenue (EV/Rev)		 2.39 2.34 2.15 1.52 1.19 1.19 1.28 1.43 1.34 1.28 0.96
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 14.38 44.72 10.28 7.58 8.82 8.14 10.87 9.48 10.10 11.49
Enterprise Value to EBIT (EV/EBIT)		 0.00 18.94 303.72 14.61 10.51 13.30 11.08 15.86 13.32 14.60 22.04
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 23.04 0.00 24.96 14.92 17.05 13.91 21.22 17.09 17.73 20.52
Enterprise Value to Operating Cash Flow (EV/OCF)		 38.90 29.58 15.79 13.05 13.36 9.99 11.67 30.41 13.94 12.48 18.02
Enterprise Value to Free Cash Flow (EV/FCFF)		 8.59 31.88 32.95 23.49 3.37 12,619.88 17.41 0.00 18.74 14.99 55.74
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.92 1.01 0.89 0.74 0.94 0.88 0.80 0.96 0.90 0.82 0.91
Long-Term Debt to Equity		 0.91 0.84 0.88 0.63 0.84 0.86 0.78 0.95 0.88 0.80 0.89
Financial Leverage		 0.49 0.57 0.60 0.59 0.63 0.65 0.56 0.66 0.79 0.72 0.73
Leverage Ratio		 2.72 2.64 2.51 2.34 2.42 2.54 2.39 2.42 2.48 2.39 2.39
Compound Leverage Factor		 4.46 1.99 -8.14 1.65 -3.90 1.27 1.46 1.54 1.62 1.46 0.58
Debt to Total Capital		 47.93% 50.21% 47.00% 42.64% 48.53% 46.77% 44.31% 49.01% 47.26% 45.07% 47.63%
Short-Term Debt to Total Capital		 0.49% 8.17% 0.59% 6.35% 5.19% 0.78% 0.93% 0.66% 0.67% 0.85% 0.99%
Long-Term Debt to Total Capital		 47.44% 42.04% 46.41% 36.29% 43.35% 45.99% 43.38% 48.35% 46.59% 44.22% 46.64%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 52.07% 49.79% 53.00% 57.36% 51.47% 53.23% 55.69% 50.99% 52.74% 54.93% 52.37%
Debt to EBITDA		 -10.44 4.80 13.95 3.94 3.66 4.78 3.84 4.94 4.35 4.55 7.61
Net Debt to EBITDA		 -6.11 2.88 9.41 3.13 2.64 3.39 2.38 4.28 3.66 3.82 6.40
Long-Term Debt to EBITDA		 -10.34 4.02 13.78 3.35 3.27 4.70 3.76 4.88 4.28 4.47 7.45
Debt to NOPAT		 -12.31 7.69 -2,006.23 9.56 7.20 9.24 6.56 9.65 7.83 8.00 13.59
Net Debt to NOPAT		 -7.20 4.61 -1,353.12 7.60 5.20 6.56 4.07 8.36 6.60 6.71 11.42
Long-Term Debt to NOPAT		 -12.19 6.44 -1,981.04 8.14 6.43 9.08 6.42 9.52 7.72 7.84 13.31
Altman Z-Score		 1.67 2.02 2.03 1.85 1.76 1.59 1.85 1.75 1.83 1.81 1.48
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.45 1.67 2.26 1.33 1.58 1.93 2.12 1.75 1.84 1.66 1.76
Quick Ratio		 1.49 1.15 1.39 0.69 0.83 1.03 1.17 0.60 0.62 0.57 0.64
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 674 173 150 144 755 0.18 154 -177 161 192 38
Operating Cash Flow to CapEx		 179.71% 268.78% 619.76% 452.71% 353.62% 0.00% 464.50% 198.44% 436.57% 408.85% 153.77%
Free Cash Flow to Firm to Interest Expense		 6.76 2.41 2.17 2.12 12.06 0.00 1.63 -2.48 2.05 2.51 0.52
Operating Cash Flow to Interest Expense		 1.49 2.60 4.53 3.81 3.04 2.66 2.44 1.43 2.75 3.02 1.62
Operating Cash Flow Less CapEx to Interest Expense		 0.66 1.63 3.80 2.97 2.18 3.21 1.91 0.71 2.12 2.28 0.57
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.41 0.48 0.51 0.55 0.58 0.56 0.58 0.59 0.60 0.60 0.59
Accounts Receivable Turnover		 6.25 8.74 9.48 9.92 9.91 10.70 13.49 15.10 18.52 20.91 17.99
Inventory Turnover		 2.61 3.74 3.65 3.62 3.42 3.18 3.44 3.25 2.78 2.68 2.70
Fixed Asset Turnover		 3.87 4.80 4.89 5.09 5.22 5.08 5.69 6.13 6.59 6.56 6.19
Accounts Payable Turnover		 3.90 5.55 5.58 5.20 5.09 5.28 5.81 5.89 6.19 6.28 5.92
Days Sales Outstanding (DSO)		 58.40 41.76 38.49 36.80 36.83 34.11 27.06 24.17 19.70 17.46 20.29
Days Inventory Outstanding (DIO)		 140.07 97.47 100.04 100.71 106.71 114.63 105.99 112.37 131.11 136.34 135.20
Days Payable Outstanding (DPO)		 93.51 65.80 65.39 70.17 71.67 69.10 62.87 61.95 58.92 58.17 61.70
Cash Conversion Cycle (CCC)		 104.96 73.43 73.14 67.33 71.87 79.63 70.18 74.59 91.89 95.63 93.79
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,868 2,935 2,784 2,775 2,191 2,327 2,366 2,689 2,704 2,675 2,740
Invested Capital Turnover		 0.74 0.81 0.80 0.80 0.86 0.86 0.89 0.86 0.84 0.84 0.82
Increase / (Decrease) in Invested Capital		 -814 67 -151 -8.50 -584 136 39 323 16 -30 66
Enterprise Value (EV)		 5,789 5,525 4,951 3,386 2,547 2,323 2,673 3,102 3,012 2,882 2,133
Market Capitalization		 4,785 4,420 3,909 2,355 1,659 1,429 1,891 1,880 1,848 1,792 946
Book Value per Share		 $29.97 $31.03 $30.57 $32.28 $24.07 $26.36 $29.14 $28.31 $30.32 $32.13 $33.43
Tangible Book Value per Share		 ($15.54) ($16.56) ($13.62) ($14.90) ($11.86) ($12.05) ($8.92) ($16.43) ($15.05) ($14.26) ($14.19)
Total Capital		 3,580 3,674 3,287 3,042 2,533 2,692 2,845 2,878 2,921 2,884 2,966
Total Debt		 1,716 1,845 1,545 1,297 1,229 1,259 1,261 1,410 1,380 1,300 1,413
Total Long-Term Debt		 1,699 1,544 1,525 1,104 1,098 1,238 1,234 1,391 1,361 1,275 1,383
Net Debt		 1,004 1,106 1,042 1,031 888 894 782 1,222 1,164 1,090 1,187
Capital Expenditures (CapEx)		 83 70 51 57 54 -48 49 51 50 57 77
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 275 145 178 161 175 130 146 233 242 188 234
Debt-free Net Working Capital (DFNWC)		 987 884 681 427 516 494 625 422 459 397 460
Net Working Capital (NWC)		 970 584 662 234 385 473 599 403 439 372 430
Net Nonoperating Expense (NNE)		 136 61 -6.47 32 543 69 74 47 62 64 79
Net Nonoperating Obligations (NNO)		 1,004 1,106 1,042 1,031 888 894 782 1,222 1,164 1,090 1,187
Total Depreciation and Amortization (D&A)		 115 93 94 98 94 89 87 90 91 88 89
Debt-free, Cash-free Net Working Capital to Revenue		 11.37% 6.15% 7.76% 7.20% 8.16% 6.64% 7.00% 10.73% 10.75% 8.33% 10.52%
Debt-free Net Working Capital to Revenue		 40.78% 37.43% 29.64% 19.12% 24.11% 25.35% 29.96% 19.42% 20.36% 17.61% 20.67%
Net Working Capital to Revenue		 40.05% 24.72% 28.79% 10.48% 17.97% 24.27% 28.69% 18.54% 19.50% 16.52% 19.34%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($4.44) $3.02 $0.10 $1.90 ($6.88) $1.25 $2.15 $1.86 $2.24 $1.98 $0.53
Adjusted Weighted Average Basic Shares Outstanding		 60.03M 57.91M 56.02M 54.04M 54.21M 54.36M 54.37M 51.44M 50.02M 48.72M 47.50M
Adjusted Diluted Earnings per Share		 ($4.44) $2.99 $0.10 $1.90 ($6.88) $1.24 $2.12 $1.84 $2.21 $1.97 $0.53
Adjusted Weighted Average Diluted Shares Outstanding		 60.03M 57.91M 56.02M 54.04M 54.21M 54.36M 54.37M 51.44M 50.02M 48.72M 47.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 60.03M 57.91M 56.02M 54.04M 54.21M 54.36M 54.37M 51.44M 50.02M 48.72M 46.46M
Normalized Net Operating Profit after Tax (NOPAT)		 122 275 243 179 203 155 209 158 189 192 137
Normalized NOPAT Margin		 5.03% 11.65% 10.58% 8.00% 9.49% 7.97% 10.00% 7.30% 8.40% 8.51% 6.16%
Pre Tax Income Margin		 -18.95% 9.31% -2.30% 7.33% -18.23% 4.48% 7.05% 5.71% 6.56% 5.36% 1.06%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -2.80 4.06 0.24 3.41 3.87 2.00 2.56 2.74 2.88 2.58 1.32
NOPAT to Interest Expense		 -1.40 3.34 -0.01 1.99 2.73 1.56 2.04 2.05 2.25 2.12 1.42
EBIT Less CapEx to Interest Expense		 -3.63 3.09 -0.50 2.57 3.01 2.55 2.04 2.02 2.25 1.84 0.27
NOPAT Less CapEx to Interest Expense		 -2.23 2.37 -0.74 1.15 1.87 2.11 1.52 1.33 1.62 1.39 0.37
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -33.85% 0.00% 0.00% 0.00% 0.00% 0.00% 21.73% 32.76% 27.46% 31.14% 115.35%
Augmented Payout Ratio		 -97.49% 110.02% 2,901.75% 120.43% 0.00% 0.00% 29.54% 158.69% 93.03% 90.47% 470.47%

Quarterly Metrics And Ratios for Edgewell Personal Care

This table displays calculated financial ratios and metrics derived from Edgewell Personal Care's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 46,716,605.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 46,716,605.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.23
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -0.52% 4.22% 0.17% -0.34% -3.09% -2.15% -3.12% -3.18% 3.79% 1.86% 0.56%
EBITDA Growth		 -11.83% -18.69% 27.56% -8.44% -41.17% -19.67% -7.24% -23.59% -134.31% -86.69% -38.83%
EBIT Growth		 -16.93% -30.08% 42.49% -9.67% -55.96% -33.72% -8.75% -30.38% -267.69% -388.52% -50.00%
NOPAT Growth		 2.15% -10.26% 29.61% 0.48% -28.94% -31.94% -22.97% -35.21% -176.43% -303.23% -71.30%
Net Income Growth		 -13.58% -61.29% 85.57% -7.55% -70.57% -143.75% -19.44% -40.61% -447.73% -3,028.57% -136.55%
EPS Growth		 -10.77% -62.50% 94.59% -3.92% -68.97% -144.44% -16.67% -36.73% -461.11% -3,425.00% -136.67%
Operating Cash Flow Growth		 61.49% 15.53% 46.26% -39.18% 54.18% -58.57% -65.04% 13.44% 119.08% -8.91% 20.40%
Free Cash Flow Firm Growth		 111.28% -103.57% -195.26% 9.00% 101.55% 9,165.63% 98.76% -152.58% -244.52% 1,293.10% 1,014.82%
Invested Capital Growth		 0.58% 0.76% 0.00% 0.29% -1.10% -0.53% 2.73% 2.67% 2.46% -11.10% -13.42%
Revenue Q/Q Growth		 -17.83% -8.46% 22.60% 8.07% -20.10% -7.57% 21.38% 8.01% -14.35% -21.30% 22.87%
EBITDA Q/Q Growth		 -33.07% -35.86% 85.92% 14.70% -56.99% -12.42% 114.69% -5.52% -119.31% 124.34% 1,113.51%
EBIT Q/Q Growth		 -42.22% -50.38% 161.24% 20.62% -71.83% -25.33% 259.65% -7.97% -167.84% 54.17% 246.59%
NOPAT Q/Q Growth		 -27.50% -55.37% 157.15% 20.75% -48.73% -57.26% 191.05% 1.57% -160.49% 47.93% 170.42%
Net Income Q/Q Growth		 -43.58% -83.95% 650.00% 36.11% -82.04% -123.86% 1,480.95% 0.34% -205.15% -114.71% 83.87%
EPS Q/Q Growth		 -43.14% -84.48% 700.00% 36.11% -81.63% -122.22% 1,600.00% 3.33% -204.84% -116.92% 84.40%
Operating Cash Flow Q/Q Growth		 -71.27% -252.51% 276.95% -21.55% -27.17% -256.85% 139.01% 154.55% -35.45% -269.91% 143.13%
Free Cash Flow Firm Q/Q Growth		 -40.22% -101.02% -836,089.49% 102.13% 10.53% -53.98% -214.59% 9.77% -203.77% 425.84% 29.86%
Invested Capital Q/Q Growth		 0.74% 3.84% -2.80% -1.36% -0.66% 4.44% 0.39% -1.42% -0.87% -9.38% -2.23%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 42.80% 40.44% 43.06% 44.32% 41.11% 40.05% 44.12% 42.81% 38.83% 38.08% 41.75%
EBITDA Margin		 14.10% 9.88% 14.98% 15.90% 8.56% 8.11% 14.34% 12.55% -2.83% 0.88% 8.64%
Operating Margin		 9.75% 5.34% 11.70% 12.77% 3.94% 4.24% 10.14% 8.56% -6.76% -4.47% 3.54%
EBIT Margin		 9.74% 5.28% 11.24% 12.55% 4.42% 3.57% 10.59% 9.02% -7.15% -4.16% 4.97%
Profit (Net Income) Margin		 5.60% 0.98% 6.01% 7.56% 1.70% -0.44% 4.99% 4.64% -5.70% -15.54% -2.04%
Tax Burden Percent		 89.79% 80.00% 76.60% 78.40% 162.96% 123.53% 70.22% 78.23% 57.52% 178.05% -134.18%
Interest Burden Percent		 64.04% 23.26% 69.73% 76.88% 23.58% -9.94% 67.15% 65.72% 138.54% 209.66% 30.62%
Effective Tax Rate		 10.21% 20.00% 23.40% 21.60% -62.96% 0.00% 29.78% 21.77% 0.00% 0.00% 49.37%
Return on Invested Capital (ROIC)		 7.31% 3.47% 14.92% 8.45% 5.38% 2.38% 5.73% 5.41% -3.88% -2.65% 1.53%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.90% 2.20% 11.91% 7.04% 3.21% 1.10% 4.72% 4.29% -4.34% -7.23% -0.22%
Return on Net Nonoperating Assets (RNNOA)		 4.68% 1.83% 9.05% 5.07% 2.32% 0.92% 3.80% 3.16% -3.15% -5.54% -0.17%
Return on Equity (ROE)		 11.99% 5.30% 23.96% 13.52% 7.70% 3.30% 9.53% 8.57% -7.04% -8.19% 1.36%
Cash Return on Invested Capital (CROIC)		 5.96% 5.44% -186.47% 6.62% 7.15% 6.13% 2.50% 1.79% 1.41% 13.57% 15.39%
Operating Return on Assets (OROA)		 5.88% 3.16% 6.80% 7.62% 2.67% 2.14% 6.26% 5.30% -4.25% -2.49% 3.04%
Return on Assets (ROA)		 3.38% 0.59% 3.63% 4.59% 1.03% -0.26% 2.95% 2.73% -3.38% -9.28% -1.25%
Return on Common Equity (ROCE)		 11.99% 5.30% 23.96% 13.52% 7.70% 3.30% 9.53% 8.57% -7.04% -8.19% 1.36%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 6.93% 7.97% 7.59% 0.00% 6.11% 5.59% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 47 21 54 65 33 14 41 42 -25 -13 9.32
NOPAT Margin		 8.76% 4.27% 8.96% 10.01% 6.42% 2.97% 7.12% 6.70% -4.73% -3.13% 1.79%
Net Nonoperating Expense Percent (NNEP)		 1.42% 1.27% 3.00% 1.41% 2.17% 1.28% 1.00% 1.12% 0.46% 4.58% 1.75%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.69% - - - 0.48% 1.39% 1.42% -0.86% -0.44% 0.34%
Cost of Revenue to Revenue		 57.20% 59.56% 56.94% 55.68% 58.89% 59.95% 55.88% 57.19% 61.17% 61.92% 58.25%
SG&A Expenses to Revenue		 21.04% 21.13% 17.93% 17.00% 21.10% 21.51% 18.20% 16.65% 20.85% 24.22% 21.37%
R&D to Revenue		 2.98% 2.72% 2.37% 2.25% 3.15% 2.91% 2.39% 2.23% 2.94% 3.26% 2.87%
Operating Expenses to Revenue		 33.05% 35.10% 31.36% 31.55% 37.17% 35.81% 33.98% 34.25% 45.59% 42.55% 38.21%
Earnings before Interest and Taxes (EBIT)		 52 26 67 81 23 17 62 57 -38 -18 26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 75 48 90 103 44 39 83 79 -15 3.70 45
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.20 1.19 1.24 1.26 1.13 1.12 0.99 0.70 0.61 0.56 0.69
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.82 0.81 0.85 0.88 0.80 0.75 0.68 0.50 0.43 0.37 0.45
Price to Earnings (P/E)		 16.12 17.11 15.54 16.64 18.17 18.36 17.77 16.99 37.24 0.00 0.00
Dividend Yield		 1.65% 1.66% 1.56% 1.49% 1.65% 1.79% 1.92% 2.56% 2.95% 3.52% 2.81%
Earnings Yield		 6.21% 5.84% 6.44% 6.01% 5.50% 5.45% 5.63% 5.89% 2.69% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.11 1.10 1.14 1.15 1.08 1.07 1.00 0.83 0.78 0.87 0.81
Enterprise Value to Revenue (EV/Rev)		 1.34 1.36 1.36 1.37 1.28 1.33 1.26 1.04 0.96 0.97 0.88
Enterprise Value to EBITDA (EV/EBITDA)		 9.48 10.10 9.51 9.82 10.10 10.79 10.38 9.37 11.49 13.40 14.86
Enterprise Value to EBIT (EV/EBIT)		 13.32 14.39 13.18 13.72 14.60 15.77 15.29 14.53 22.04 29.60 41.79
Enterprise Value to NOPAT (EV/NOPAT)		 17.09 17.86 16.79 16.72 17.73 18.99 19.46 19.01 20.52 45.20 74.71
Enterprise Value to Operating Cash Flow (EV/OCF)		 13.94 13.48 11.47 15.15 12.48 15.81 26.78 19.47 18.02 20.02 16.85
Enterprise Value to Free Cash Flow (EV/FCFF)		 18.74 20.35 0.00 17.45 14.99 17.35 40.49 47.03 55.74 6.05 4.91
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.90 0.96 0.89 0.83 0.82 0.98 0.96 0.89 0.91 1.05 0.88
Long-Term Debt to Equity		 0.88 0.94 0.87 0.82 0.80 0.96 0.95 0.88 0.89 1.02 0.86
Financial Leverage		 0.79 0.83 0.76 0.72 0.72 0.84 0.81 0.74 0.73 0.77 0.77
Leverage Ratio		 2.48 2.48 2.42 2.39 2.39 2.46 2.46 2.39 2.39 2.50 2.47
Compound Leverage Factor		 1.59 0.58 1.69 1.84 0.56 -0.24 1.65 1.57 3.31 5.24 0.76
Debt to Total Capital		 47.26% 48.85% 46.98% 45.42% 45.07% 49.44% 49.10% 47.10% 47.63% 51.10% 46.91%
Short-Term Debt to Total Capital		 0.67% 0.80% 0.81% 0.74% 0.85% 0.92% 0.91% 0.78% 0.99% 1.07% 1.29%
Long-Term Debt to Total Capital		 46.59% 48.05% 46.17% 44.68% 44.22% 48.52% 48.18% 46.31% 46.64% 50.03% 45.62%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 52.74% 51.15% 53.02% 54.58% 54.93% 50.56% 50.90% 52.90% 52.37% 48.90% 53.09%
Debt to EBITDA		 4.35 4.82 4.22 4.15 4.55 5.32 5.42 5.70 7.61 9.62 9.62
Net Debt to EBITDA		 3.66 4.12 3.62 3.53 3.82 4.68 4.79 4.88 6.40 8.24 7.37
Long-Term Debt to EBITDA		 4.28 4.74 4.14 4.08 4.47 5.22 5.32 5.60 7.45 9.42 9.36
Debt to NOPAT		 7.83 8.52 7.44 7.06 8.00 9.36 10.17 11.55 13.59 32.44 48.36
Net Debt to NOPAT		 6.60 7.28 6.38 6.00 6.71 8.24 8.98 9.90 11.42 27.78 37.03
Long-Term Debt to NOPAT		 7.72 8.38 7.32 6.94 7.84 9.19 9.98 11.36 13.31 31.76 47.03
Altman Z-Score		 1.68 1.66 1.72 1.79 1.65 1.65 1.60 1.48 1.36 1.35 1.51
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.84 2.15 1.84 1.79 1.66 2.06 1.89 1.77 1.76 2.12 1.81
Quick Ratio		 0.62 0.70 0.60 0.66 0.57 0.64 0.65 0.62 0.64 0.76 0.79
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 31 -0.32 -2,676 57 63 29 -33 -30 -91 297 386
Operating Cash Flow to CapEx		 259.78% -1,121.54% 1,121.74% 803.17% 284.56% -688.10% 263.74% 740.65% 268.48% -1,085.34% 387.86%
Free Cash Flow to Firm to Interest Expense		 1.67 -0.02 -131.17 3.03 3.60 1.54 -1.65 -1.55 -6.16 15.38 21.54
Operating Cash Flow to Interest Expense		 2.56 -3.68 6.32 5.38 4.21 -6.15 2.23 5.92 5.01 -6.52 3.03
Operating Cash Flow Less CapEx to Interest Expense		 1.57 -4.01 5.76 4.71 2.73 -7.04 1.39 5.12 3.14 -7.12 2.25
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.60 0.60 0.61 0.61 0.60 0.60 0.59 0.59 0.59 0.60 0.61
Accounts Receivable Turnover		 18.52 16.62 17.40 16.42 20.91 19.25 14.41 14.30 17.99 16.26 12.29
Inventory Turnover		 2.78 2.49 2.63 2.71 2.68 2.53 2.53 2.70 2.70 2.74 2.79
Fixed Asset Turnover		 6.59 6.72 6.94 6.83 6.56 6.63 6.62 6.47 6.19 7.03 7.05
Accounts Payable Turnover		 6.19 5.98 5.95 5.77 6.28 6.45 5.87 5.89 5.92 6.32 6.00
Days Sales Outstanding (DSO)		 19.70 21.96 20.98 22.23 17.46 18.96 25.33 25.52 20.29 22.45 29.70
Days Inventory Outstanding (DIO)		 131.11 146.61 138.55 134.68 136.34 144.39 144.16 135.19 135.20 133.34 130.99
Days Payable Outstanding (DPO)		 58.92 61.08 61.32 63.21 58.17 56.62 62.22 62.02 61.70 57.74 60.81
Cash Conversion Cycle (CCC)		 91.89 107.49 98.21 93.70 95.63 106.74 107.28 98.69 93.79 98.05 99.89
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,704 2,808 2,730 2,692 2,675 2,793 2,804 2,764 2,740 2,483 2,428
Invested Capital Turnover		 0.84 0.81 1.67 0.84 0.84 0.80 0.80 0.81 0.82 0.85 0.85
Increase / (Decrease) in Invested Capital		 16 21 2,730 7.80 -30 -15 75 72 66 -310 -376
Enterprise Value (EV)		 3,012 3,095 3,100 3,107 2,882 2,976 2,795 2,297 2,133 2,164 1,977
Market Capitalization		 1,848 1,832 1,922 1,992 1,792 1,684 1,505 1,101 946 834 997
Book Value per Share		 $30.32 $30.85 $31.07 $31.82 $32.13 $30.82 $31.39 $33.34 $33.43 $30.38 $31.00
Tangible Book Value per Share		 ($15.05) ($15.20) ($14.88) ($14.30) ($14.26) ($15.65) ($15.53) ($14.97) ($14.19) ($9.67) ($10.70)
Total Capital		 2,921 3,022 2,926 2,888 2,884 2,969 2,974 2,964 2,966 3,040 2,728
Total Debt		 1,380 1,477 1,374 1,312 1,300 1,468 1,460 1,396 1,413 1,553 1,280
Total Long-Term Debt		 1,361 1,452 1,351 1,290 1,275 1,441 1,433 1,373 1,383 1,521 1,244
Net Debt		 1,164 1,262 1,178 1,116 1,090 1,292 1,290 1,196 1,187 1,330 980
Capital Expenditures (CapEx)		 18 6.50 12 13 26 17 17 16 28 12 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 242 348 280 249 188 338 333 261 234 369 231
Debt-free Net Working Capital (DFNWC)		 459 562 477 445 397 513 503 461 460 592 531
Net Working Capital (NWC)		 439 538 453 424 372 486 476 437 430 560 496
Net Nonoperating Expense (NNE)		 17 16 18 16 24 16 12 13 5.19 52 20
Net Nonoperating Obligations (NNO)		 1,164 1,262 1,178 1,116 1,090 1,292 1,290 1,196 1,187 997 980
Total Depreciation and Amortization (D&A)		 23 23 22 22 21 22 22 22 23 21 19
Debt-free, Cash-free Net Working Capital to Revenue		 10.75% 15.31% 12.34% 10.96% 8.33% 15.06% 14.98% 11.84% 10.52% 16.53% 10.34%
Debt-free Net Working Capital to Revenue		 20.36% 24.74% 20.97% 19.60% 17.61% 22.89% 22.63% 20.89% 20.67% 26.54% 23.76%
Net Working Capital to Revenue		 19.50% 23.68% 19.93% 18.66% 16.52% 21.67% 21.40% 19.84% 19.34% 25.08% 22.19%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.58 $0.10 $0.72 $0.99 $0.17 ($0.04) $0.60 $0.62 ($0.65) ($1.41) ($0.23)
Adjusted Weighted Average Basic Shares Outstanding		 50.02M 49.93M 49.55M 49.31M 48.72M 48.70M 48M 46.80M 47.50M 46.60M 46.50M
Adjusted Diluted Earnings per Share		 $0.58 $0.09 $0.72 $0.98 $0.18 ($0.04) $0.60 $0.62 ($0.65) ($1.41) ($0.22)
Adjusted Weighted Average Diluted Shares Outstanding		 50.02M 49.93M 49.55M 49.31M 48.72M 48.70M 48.20M 47M 47.60M 46.60M 46.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 50.02M 49.93M 49.55M 49.31M 48.72M 48.23M 47.03M 46.46M 46.46M 46.72M 46.08M
Normalized Net Operating Profit after Tax (NOPAT)		 54 26 56 67 30 17 50 55 -15 -0.56 16
Normalized NOPAT Margin		 10.09% 5.38% 9.37% 10.38% 5.84% 3.58% 8.60% 8.69% -2.71% -0.13% 3.16%
Pre Tax Income Margin		 6.23% 1.23% 7.84% 9.65% 1.04% -0.36% 7.11% 5.93% -9.90% -8.73% 1.52%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 2.78 1.30 3.30 4.32 1.31 0.91 3.04 2.92 -2.59 -0.91 1.44
NOPAT to Interest Expense		 2.50 1.05 2.63 3.45 1.90 0.76 2.05 2.17 -1.72 -0.69 0.52
EBIT Less CapEx to Interest Expense		 1.80 0.97 2.74 3.65 -0.17 0.02 2.20 2.12 -4.46 -1.51 0.66
NOPAT Less CapEx to Interest Expense		 1.52 0.73 2.07 2.78 0.42 -0.14 1.20 1.37 -3.58 -1.29 -0.26
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 27.46% 28.76% 25.22% 25.90% 31.14% 33.81% 35.54% 45.99% 115.35% -75.39% -36.76%
Augmented Payout Ratio		 93.03% 98.97% 86.26% 84.54% 90.47% 114.29% 146.40% 213.43% 470.47% -232.20% -88.56%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Edgewell Personal Care (NYSE:EPC) based on quarterly results over the last four years, focusing on trends that may matter to retail investors.

  • Revenue resilience: Edgewell has hovered in the mid-to-high 500s million per quarter, with a notable peak of 627.2 million in Q3 2025, suggesting ongoing demand for its consumer brands.
  • Gross margin stability: Gross margins have generally run in the 40% to 45% range (e.g., ~42%+ in several quarters), indicating relatively stable product profitability despite mix and pricing dynamics.
  • Consistent pockets of profitability: Several quarters posted positive net income (e.g., Q3 2024 at ~52.9 million; Q2 2025 at ~29.0 million; Q3 2025 at ~29.1 million), signaling improving earnings under certain conditions.
  • Operating cash flow was positive in multiple periods: Notably, Q3 2025 produced about 114.8 million from continuing operating activities, and Q4 2024 generated roughly 73.7 million, indicating periods of solid cash generation.
  • Dividends maintained: A cash dividend of 0.15 per share is being paid, reflecting ongoing capital return to shareholders.
  • Restatements and data revisions: The earnings history includes quarters labeled as restated or calculated in the data, which can affect comparability across periods.
  • Working capital and seasonality: Inventories and working capital levels show quarter-to-quarter variation typical for consumer staples, reflecting seasonality and category mix rather than a single directional trend.
  • Steady asset base with manageable scale: Total assets have typically ranged in the low-to-mid 3s billions (about 3.7–3.8b in many periods), suggesting a stable balance-sheet size over the four-year window.
  • Significant leverage and debt service: Long-term debt around 1.5 billion and total liabilities near 2.28 billion as of mid-late 2020s, plus ongoing interest expenses in the teens to low 20 millions per quarter, implying meaningful debt service burden.
  • Near-term profitability and cash-flow swings: In some recent quarters, net income turned negative (e.g., Q1 2026 shows a net loss of about 65.7 million) and cash flow from operations also turned negative (e.g., net cash from continuing operating activities around -125.9 million), highlighting volatility and potential near-term earnings and liquidity pressure.
05/27/26 09:19 PM ETAI Generated. May Contain Errors.

Edgewell Personal Care Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Edgewell Personal Care's fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

Edgewell Personal Care's net income appears to be on an upward trend, with a most recent value of $25.40 million in 2025, falling from -$275.30 million in 2015. The previous period was $98.60 million in 2024. Find out what analysts predict for Edgewell Personal Care in the coming months.

Edgewell Personal Care's total operating income in 2025 was $96.60 million, based on the following breakdown:
  • Total Gross Profit: $924.90 million
  • Total Operating Expenses: $828.30 million

Over the last 10 years, Edgewell Personal Care's total revenue changed from $2.42 billion in 2015 to $2.22 billion in 2025, a change of -8.2%.

Edgewell Personal Care's total liabilities were at $2.20 billion at the end of 2025, a 2.6% increase from 2024, and a 29.4% decrease since 2015.

In the past 10 years, Edgewell Personal Care's cash and equivalents has ranged from $188.70 million in 2022 to $738.90 million in 2016, and is currently $225.70 million as of their latest financial filing in 2025.

Over the last 10 years, Edgewell Personal Care's book value per share changed from 29.97 in 2015 to 33.43 in 2025, a change of 11.5%.


Related Companies

Financial statements for NYSE:EPC last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel